Article · 9 Nov 2026
Conference abstract
SStudy of domperidone in the stimulation of milk synthesis
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is well known that breastmilk is incredibly important to the neonatal outcome in premature infants. Thus maintaining a good milk production in the mothers of this population will go a long way in preventing unnecessary disease in these infants. Domperidone works by stimulating the production of prolactin in women that have insufficient plasma prolactin levels. Prolactin levels at birth are approximately 300 ng/mL, and drop quickly in some mums to levels approximating 10-20 ng/mL (normal non-lactating levels). At these lower levels, milk synthesis slows or ceases. Domperidone in a modest dose of 10-20 mg TID is well known to maintain plasma prolactin levels in the 120 ng/mL range, thus dramatically stimulating milk synthesis. At present, domperidone is used all over the world for this purpose. However, domperidone is a known HERG (potassium channel) receptor antagonist, and can increase the QT interval in rare individuals. This is almost always dose-related, and is found usually in those patients who are already prone to QT interval interruption and are older. We will perform a study which will use a low dose of domperidone to stimulate prolactin levels (10 mg TID). Worldwide, domperidone has been used at excessively high doses (40 mg QID) by some physicians. Several recent studies support the contention that excessive domperidone doses do not produce higher levels of prolactin. Apparently, prolactin release from the pituitary is almost maximal at a 10 mg TID dose, with only slightly higher plasma levels produced at 20 mg TID. Thus, 10 mg doses are fully active in stimulating milk production, and these higher doses are probably unnecessary.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical & Experimental Pharmacology.
Article · 23 Feb 2026
A Thorough Overview of Polycystic Ovary Syndrome (PCOS) in Female Rats
Article · 19 Dec 2025
Theoretical Pharmacology: Understanding Drug Action Through Models and Principles
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Pharmacology
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Raphae Serreau”
